ArticleBMC genomics2025
Fusion_f5C-Pred: a dual-branch feature fusion framework for 5-formylcytosine modification sites prediction.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
background5-formylcytidine (f5C) is a unique post-transcriptional RNA modification present at the wobble position of mRNAs and tRNAs, that plays a critical role in mitochondrial protein synthesis and is potentially involved in translation regulation. Recent studies have revealed that f5C modifications may promote cancer metastasis by driving mitochondrial mRNA translation. However, existing computational methods for predicting f5C modification sites are scarce and have significant limitations, which has hindered in-depth investigations into their molecular functions and regulatory mechanisms.
resultsTo address these limitations, we developed Fusion_f5C-Pred, an innovative dual-branch deep learning framework that integrates both sequence and structural features through a gated fusion network. The sequence branch employs a densely connected convolutional network integrated with the convolutional block attention module to capture local sequence patterns, whereas the structural branch utilizes the transformer-encoder to learn RNA secondary structure features. Comprehensive evaluations of independent datasets demonstrate that Fusion_f5C-Pred achieves superior prediction performance with an ACC of 0.7952 and an AUROC score of 0.8684, significantly outperforming existing methods. The t-SNE visualization analysis confirms that the fused features exhibit enhanced inter-class separation in the representation space.
conclusionsNotably, our model's learned sequence patterns strongly agree with known RNA regulatory motifs identified via MEME, indicating biological interpretability. The proposed framework not only offers a robust computational tool for f5C research but also establishes a transferable architecture for studying other RNA modifications. The source code and datasets are publicly available at: https://github.com/HuiCong123/Fusion_f5C-Pred .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.